In vivo oxidized low-density lipoprotein (ox-LDL) aopp and tas after kidney transplantation: a prospective, randomized one year study comparing cyclosporine A and tacrolimus based regiments

Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia
Josef ZadražilHelena Vaverkova

Abstract

Restoration of renal function after kidney transplantation (KT) is expected to improve oxidative stress (OS). However, little is known about the influence of calcineurin inhibitors on oxidized low-density lipoproteins (ox-LDL) after KT. The aim of this study was to evaluate ox-LDLs and related markers of OS, advanced oxidation protein products (AOPP) and total antioxidant status (TAS) in patients after KT on either cyclosporin A (CyA) or tacrolimus (Tac) treatment. This was a prospective, randomized, single-center 12 month study evaluating time-dependent changes in biomarkers of OS before and after KT. Twenty nine patients (mean age 54.4 ± 11.1; 55% male and 45% female) were treated with CyA (Group A) and twenty four patients (mean age 52.9 ± 9.9; 75% male and 25% female) were treated with Tac (Group B). The ox-LDL, AOPP, TAS, lipid metabolism parameters, creatinine and glomerular filtration were assessed on day 1 before KT and on days 1 and 7, and in months 1, 3, 6 and 12 after KT. Over the 12 months, the ox-LDL for group A changed from 69.2±32.9 to 65.1±17.1 U/L (P=0.665), while AOPP significantly decreased from 233.0±159.6 to 156.5±90.1 μmol/L (P=0.025) and TAS from 1.87±0.31 to 1.68±0.20 mmol/L (P=0.030). For group B the ox...Continue Reading

References

May 1, 1996·Kidney International·V Witko-SarsatB Descamps-Latscha
Sep 29, 1999·Transplantation Proceedings·F CofanF Oppenheimer
Mar 11, 2000·Arteriosclerosis, Thrombosis, and Vascular Biology·P HolvoetJ Vanhaecke
Dec 1, 2001·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·R S Gaston
Apr 10, 2002·Clinical Chemistry and Laboratory Medicine : CCLM·GianMario GerardiLorenzo Diego Di
Apr 18, 2002·Transplantation Proceedings·F CofanF Oppenheimer
Oct 17, 2002·American Journal of Nephrology·Lelija ZezinaBengt Fellström
Apr 16, 2003·Kidney International. Supplement·Véronique Witko-SarsatBéatrice Descamps-Latscha
Jun 17, 2003·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Francesco LocatelliCarmine Zoccali
Dec 6, 2003·Transplantation·Mariarosaria CampiseClaudio Ponticelli
Jun 18, 2004·Kidney International·Didier DuclouxJean-Marc Chalopin
Jun 25, 2004·Advances in Chronic Kidney Disease·Fred E YeoKevin C Abbott
Sep 14, 2004·Nephron. Clinical Practice·Sabine H A DiepeveenAnton F H Stalenhoef
Dec 24, 2004·Journal of the American Society of Nephrology : JASN·Krista L LentineMark A Schnitzler
Feb 8, 2005·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Béatrice Descamps-LatschaPaul Jungers
Jan 3, 2006·Transplantation Proceedings·F CofanF Oppenheimer
Feb 25, 2006·Arteriosclerosis, Thrombosis, and Vascular Biology·Shang Xi LiuXun Zhang
Jul 25, 2006·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Guillermo ZalbaJavier Díez
Jul 10, 2007·Seminars in Nephrology·Ignatius Y TangBruce Kaplan
Jan 10, 2008·Blood Purification·Massimo de CalClaudio Ronco
Dec 23, 2008·Clinical Chemistry and Laboratory Medicine : CCLM·Eline VerhoyeUNKNOWN Asklepios Investigators
Jan 19, 2010·Clinical Biochemistry·Josef ZadrazilPetr Schneiderka

❮ Previous
Next ❯

Citations

Jul 31, 2013·Journal of Tissue Engineering and Regenerative Medicine·Rodrigo Antonio Parra TeixeiraSonia Maria Oliani
Sep 1, 2016·Health Technology Assessment : HTA·Tracey Jones-HughesRob Anderson
May 13, 2017·Redox Report : Communications in Free Radical Research·Larissa Vieira MarinoPaula Garcia Chiarello
Jun 29, 2016·Cardiovascular Toxicology·Hanxiao OuJi Xiao

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Related Papers

Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia
Marie LazárováMartina Skácelová
Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia
Marcela SkvarilováJosef Bartek
© 2021 Meta ULC. All rights reserved